COMMUNIQUÉS West-GlobeNewswire

MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
08/07/2026
90.5% interim disease control rate (DCR) observed with combination therapy Initial Part C efficacy observations align with previously reported THIO-101 clinical activity despite a more heavily pre-treated patient [...]
Cannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use Detection
08/07/2026
Expanded breath-testing capability enables recent-use detection across a panel modeled after the DOT federally mandated urine drug test panel. VANCOUVER, British Columbia, July 08, 2026 (GLOBE NEWSWIRE) -- Cannabix [...]
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
08/07/2026
MONTREAL, July 08, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, the “ Company ”, “ us ” or “ we ”) ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
American Physical Therapy Association and Inteleos Activate Partnership with First Joint Educational Program for Musculoskeletal Ultrasound Imaging Standards and Certification
08/07/2026
Free one-day course at APTA's Centennial Center in Alexandria, Virginia marks the partnership's first concrete step toward a profession-wide MSK imaging standards ALEXANDRIA, Va., July 08, 2026 (GLOBE NEWSWIRE) -- The [...]
SRX Global Declares One-Time Cash Dividend
08/07/2026
Company delivering $1 million in aggregate to shareholders via cash dividend payment from profits related to investment in SpaceX and hedging strategies NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX [...]
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
08/07/2026
RUTHERFORD, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel [...]
As America Celebrates its 250th Birthday, Becoming Independent Marks 59 Years of Helping People Live on Their Own Terms
08/07/2026
Becoming Independent Named No. 17 on “The NonProfit Times' 2026 Best Nonprofits To Work For” SANTA ROSA, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Becoming Independent , the North Bay's leading nonprofit serving adults [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/07/2026
BRISBANE, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
08/07/2026
This first-in-class differentiated approach will be highlighted during a Featured Research Session entitled Alzheimer's therapy: mechanisms beyond amyloid ROCHESTER, N.Y., July 08, 2026 (GLOBE NEWSWIRE) -- Vaccinex, Inc [...]
Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247
08/07/2026
All four participants showed a decline in fat fraction as measured by MRI, with a mean improvement of 3.7% from 49.7% at TRAILHEAD baseline to 46.0% at month 6, suggesting improved muscle composition All four [...]
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
08/07/2026
July 16 in Boston, management will engage with investors and industry participants at the healthcare-focused event covering neuropsychiatry, neurodegeneration, neuromuscular disease, ophthalmology, and neuroimmunology [...]
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
08/07/2026
Urges Stockholders to Vote “FOR” ONLY Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”) today issued a letter to [...]
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
08/07/2026
Proposed acquisition of an Israeli company with approximately 20 years of operating experience is expected to strengthen BiomX's Detection-Analysis-Response strategy through security systems, fire detection, access [...]
J-Star Holding Holding Co., Ltd Announces 1-for-5 Share Consolidation
08/07/2026
TAICHUNG CITY, Taiwan, July 08, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today announced that it plans to implement a 1-for-5 share consolidation of its Class A [...]
Shopify to Announce Second-Quarter 2026 Financial Results
08/07/2026
Internet, Everywhere, July 08, 2026 (GLOBE NEWSWIRE) -- Shopify Inc. (NASDAQ, TSX: SHOP) plans to announce financial results for the quarter ended June 30, 2026 before markets open on Wednesday, August 5, 2026. Shopify’ [...]
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
08/07/2026
FDA alignment on a single-dose Phase 3 study design and potential single-trial registration pathway further strengthens the Company's clinical development program for urcosimod Company unveils NEPTUNE ( N europathic E [...]
Nonprofit Launches One of the Nation’s Most Comprehensive Education Resources for Inherited Retinal Diseases
08/07/2026
Free platform empowers patients and families with information on 53 diseases, 125 genes, active clinical trials, treatment pipelines, and support resources GILBERT, Ariz., July 08, 2026 (GLOBE NEWSWIRE) -- Today, as co- [...]
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
08/07/2026
Kevin Norrett, a proven leader in advancing corporate strategy through value-creating transactions, will be appointed as Chief Business Officer Charles Carter promoted to Chief Financial Officer, reflecting his strong [...]
Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment
08/07/2026
80% of SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the Investigator-Sponsored Trial (IST) conducted by Memorial Sloan Kettering Cancer Center [...]

Pages